Abstract
Delivery of drugs through the skin has been always a challenging area for research due to barrier properties exhibit by the outermost layer of skin stratum corneum. In the last two decades, the transdermal drug delivery system has become a proven technology that offers significant clinical benefits over other dosage forms. Because transdermal drug delivery offers controlled as well as predetermined rate of release of the drug into the patient, it able to maintain steady state blood concentration. It’s a desirable form of drug delivery because of the obvious advantages e.g.convenient and pain-free self-administration for patients, avoidance of hepatic first-pass metabolism and the GI tract for poorly bioavailable drugs over other routes of delivery. The outlook for continued growth of the TDD market is very optimistic.Transdermal drug delivery has made an important contribution to medical practice, but has yet to fully achieve its potential as an alternative to oral delivery and hypodermic injections. This review emphasizes the three generations of transdermal drug delivery which start a new era of delivery of drug.
References
Wilson Ellen Jett,2011 Three Generations: The Past, Present, and Future of Transdermal Drug Delivery Systems
Shingade, G.M., Aamer, Q., Sabale, P.M., Grampurohit, N.D., Gadhave ,M.V.,2012. Review on: recent trend on transdermal drug delivery system, Journal of Drug Delivery & Therapeutics 2 (1), 66-75.
Matteucci, M.,Casella,M., Bedoni,M.,Donetti, E., Fanetti,M.,Angelis, F. D.F., Gramatica,F.,Fabrizio, E. D.,2008. A compact and disposable transdermal drug delivery system, Microelectronic Engineering 85,1066-1073
Paudel,K.S.,Milewski,M.,Swadley,C.L.Brogden,N.K., Ghosh,P.,Stinchcomb,A.L.,2010. Challenges and opportunities in dermal/transdermal delivery,TherDeliv. 1(1),109–131.
Alexander,A.,Dwivedi,S.,Ajazuddin,giri,T.K.,Saraf,S., Saraf,S.,Tripathi,D.K.,2012. Approaches for breaking the barriers of drug permeation through transdermal drug delivery, Journal of Controlled Release 164,26-40.
Prausnitz, M.R., Langer,R., 2008. Transdermal drug delivery,Nat Biotechnol.26(11),1261-1268
Kaestli,L.Z., Wasilewski-Rasca,A.F., Bonnabry,
P., Vogt-Ferrier N.,2008. Use of transdermal drug formulations in the elderly. Drugs Aging. 25(4), 269-280.
Vishwakarma,S.K.,NiranjanS.K.,Irchhaiya,R.,Kumar,N
.,Akhtar,A.,2012.A Novel transdermal drug delivery system,International Journal of research of pharmacy 3(8),39-44
Shingade,G.M.,Aamer,Q.,Sabale,P.M.,Gramprohit, N.D.,Gadhave,M.V.,Jadhv,S..L,Gaikwad, D.D.2012.,Review on: recent trend on transdermal drug delivery system, Journal of Drug Delivery & Therapeutics 2 (1) , 66-75
Hanumanaik, m., Patil,u., Kumar,g., Patel,s.k., Singh,i., Jadatkar,k.,2012. DESIGN, EVALUATION AND RECENT TRENDS IN TRANSDERMAL DRUG DELIVERY SYSTEM: A REVIEW, International Journal of pharmaceutical sciences and research 3(8),2393- 2406
Rastogi, V., Yadav,P., 2012. Transdermal drug delivery system: An overview, Asian Journal Of Pharmaceutics 6(3),161-170
Arunachalam,A., ,Karthikeyan, M., Kumar,V. D., Prathap, M., Sethuraman, S., Ashutoshkumar, S., Manidipa, S., 2010.Transdermal Drug Delivery System: A Review, Current Pharma Research 1(1) , 70-81.
Kapoor D., Patel, M. and Singhal M., 2011.Innovations in Transdermal drug delivery system, International PharmaceuticaSciencia 1 (1) , 54-61
Keleb,E., Sharma, R.K., MosaEsmaeil, B., Abd- alkadar Z aljahwi, 2010.Review on Transdermal Drug Delivery System- Design and Evaluation, International Journal of Advances in Pharmaceutical Sciences 1 , 201-211.
Patel, D., Sunita, A.,Parmar ,B.,Bhura, N., 2012.Transdermal Drug Delivery System: A Review, THE PHARMA INNOVATION 1(4), 66-75.
Sharma ,N. , Agarwal, G., Rana, A.C., Ali Bha,tZ.,Kumar ,D.,2011. A Review: Transdermal Drug Delivery System: A Tool For Novel Drug Delivery System, International Journal of Drug Development & Research 3(3), 70-84.
Das, U. S.,Pande K.H.,2013. AN OVERVIEW OF DIABETES MELLITUS, World journal Of Pharmacy and Pharmaceutical sciences 2(1),161-178
Chatsiricharoenkul ,S., Pongnarin, P., 2007.Bioequivalence Study of 30 mg Pioglitazone Tablets in Thai Healthy Volunteers J Med Assoc Thai 90 (3), 564-8
Mathur, V., Satrawala ,Y., Rajput, M. S.,2010, Physical and chemical penetration enhancers in transdermal drug delivery system Asian Journal Of Pharmacy 4 (3) ,173-183
Shahnawaz, M.,Kurkarni,A.P.,Zaheer,Z.,Dehghan,M.H.,2012.Spec troscopic estimation of pioglitazone hydrochloride
,International journal of pharmaceutical frontier research 2 (1),87-94
Mehta,R.S.,Patel,D.M.,Bhatt,K.K.,Shankar,M.B.,2005, Uv and visible spectrophotometric analysis of pioglitazone hydrochloride in bulk and tablets, Indian journal of pharmaceutical sciences, 87-89
Rai, A. K., Rai, D.K.,2003. Spectroscopic studies of some antidiabetic drugs, SpectrochimicaActa Part A59 , 1673-1680.
Ryan D. Gordon ,Tim A. Peterson , http://drug- dev.com/Main/Back-Issues/4-Myths-About Transdermal - Drug-Delivery-169.
Som,I.,Bhatia, K.,Yasir,M.,2012.Status of surfactants as Penetration Enhancers in transdermal drug delivery, Journal Of Pharmacy &Bioallied Science 4 (1) ,2-9.
Robinson Joseph R.,Lee Vincent H.L.,Controlled Drug Release Fundamentals and Applications,2nd edition
Tripathi K.D., Essentials Of Mediacal Pharmacology,6th edition, Oral Hypoglycemic Drugs,269-270
Chien Y.W, “Novel Drug Delivery Systems”. 2009.
(50): 301.
Jain N.K., INTRODUCTION TO NOVEL DRUG DELIVBERY SYSTEMS, Transdermal Drug Delivery,97-117
Indian Pharmacopoeia 2010,Government Of Indian Ministry Of Health & Family Welfare Vol.III. pg no. 1917
Sinha V. R. andManinder Pal Kaur2000. Permeation Enhancers for Transdermal Drug Delivery Drug Development and Industrial Pharmacy, 26(11) , 1131–1140
Lachman,L.,Lieberman,H.A.,2009.The Theory and Practice of industrial Pharmacy, Preformulation, suatained release dosage form 171-194 and 430- 456.
Gennaro,A.R.,Remington:The science and practice of pharmacy Volume I,21stEdition,Preformulation and Controlled –Release Drug Delivery System,700-719 and917-918
Chatwal,G.R.,Anand,S.K.,2009.Instrumental Methods Of Chemical analysis,Infrared absorption Spectroscopy 2.62-2.71
Chand,S.,Elementary Organic Spectroscopy, Principles and chemical applications,91-134.
Rowe,R.C.,Sheskey,P.J.,Owen,S.C., Handbook of Pharmaceutical Excipients, Fifth edition.
Rangari N.T., Kalyankar T.M., Puranik P.K., Chaudhar S.R.,2012. Permeation studies of pioglitazone hcl from ficuscarica fruit mucilage matrix transdermal patches,International journal of pharmaceutical sciences and research 3(10),3927- 3931.
Kim MK, Zhao H, Lee CH, Kim DD,2001. Formulation of a reservoir-type testosterone transdermal delivery system .Int J Pharm.219(1-2), 51-9.
M. Aqil and AsgarAli ,2002.Monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: in vitro characterisation, European Journal of Pharmaceutics and Biopharmaceutics 54
,161–164.
Raghuraman,S.,Velrajan, Ravi,R., Jeybalan,B., Johnson,D.B., and Sankar,V.,2001.Design and Evaluation of Propranolol Hydrochloride Buccal films,Indian Journal Of pharmaceutical sciences 61(1),32-36.
Gupta,R., Mukherjee,B.,2003. Development and in vitro evaluation of diltiazem hydrochloride transdermal patches based on povidone- ethylcellulose matrices,Drug DevInd Pharm. 29(1),1- 7
Mutalik, S., Udupa, N.,2004. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations, J Pharm Sci 23(6), 1577-94
Davaran,S.,Rashidi,M.R..,Khandaghi, R.,Hashemi, M.,2005. Development of a novel prolonged- release nicotine transdermal patch,Pharmacological Research 51 , 233–237.
Mukherjee, B., Mahapatra, S. ,Gupta,R., Patra,B.,Tiwari,A.,Arora, P.,2005. A comparison between povidone-ethylcellulose and povidone- eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation,European Journal of Pharmaceutics and Biopharmaceutics 59 , 475–483
Das,M.K., Bhattacharya,A., Ghosal,S.K.,2006.Transd ermal delivery of trazodone hydrochloride from acrylic films prepared from aqueous latex,Indian Journal Of Pharmaceutical sciences, 68(1),41-46.
Gupta,R.,Bajpai,M.,.Bhattacharya,A.,2008.Formulati on and in vitro evaluation of transdermal drug delivery system of TizanidineHydrochloride,Journal Of pharmaceutical Research 7 (4) , 208-213
Limpongsa,E., Umprayn,K.,2008. Preparation and Evaluation of Diltiazem Hydrochloride Diffusion- Controlled Transdermal Delivery System, AAPS PharmSciTech. 9(2), 464–470.
Yellela S. Krishnaiah,Saleh M. Al-Saidan,2008. Limonene Enhances the In Vitro and In Vivo Permeation of Trimetazidine Across aMembrane- Controlled Transdermal Therapeutic System,Current Drug Delivery 5,70-76
Melero,A.,Garrigues,T.M.,Almudever,P., Villodre,A. M., Lehr,C.M. Schafer,U. 2008. Nortriptyline hydrochloride skin absorption:Development of a transdermal patch, European Journal of Pharmaceutics and Biopharmaceutics69 , 588–596
Sadashivaiah,R., Dinesh, B.M.,Patil,U. A., Desai,B.G., Raghu,K.S., 2008. Design and in vitro evaluation of haloperidol lactate transdermal patches containing ethyl cellulose-povidone as film formers,Asian Journal Of Pharmaceutics 2(1),43-49.
Shinde,A. J.,Garala,K. C., More,H. N., 2008. Development and characterization of transdermal therapeutics system of tramadol hydrochloride, Asian Journal Of Pharmaceutics 2(4),265-269.
Murthy,T.E.G.K.,Saikishore,V.,2008. Effect of casting solvent and polymer on permeability of propranolol hydrochloride through membrane-controlled transdermal drug delivery system, Asian Journal Of Pharmaceutics 2(2),86-90.
Ren,C.,Fang,L., Ling,L.,Wang,Q.,Liu,S.,Zhao,L.G., He,Z.,2009. Design and in vivo evaluation of an indapamide transdermal patch,International Journal of Pharmaceutics 370,129-135.
Sun,Y.,Fang,L.,Zhu,M.,Li,W.,Meng,P.,Li,L. He,Z.,2009.drug-in-adhesive transdermal patch for S-amlodipine free base: In vitro and in vivo characterization,International Journal of Pharmaceutics 382,165-171.
Gupta,J.R.D.,Irchhiaya,R.,Garud,N.,Tripathi,P.,Dubey
,P.,Patel,J.R.,2009.Formulation and Evaluation of matrix type transdermal patches of Glibenclamide,International journal of Pharmaceutical sciences and Research 1(1),46-50.
Chandra,A.,Shrma,P.K.,2009.Transdermal delivery of Ketorolac,the pharmaceutical society of japan 129(3),373-379.
Jamakandi,V.G.,Mulla,J.S.,Vinay,B.L.,Shivakumar,H. N., 2009. Formulation, characterization, and evaluation of matrix-type transdermal patches of a model antihypertensive drug, Asian Journal Of Pharmaceutics 3(1),59-65.
Shah,S.S.,Joshi,R.,Prabhu,P., 2010. Formulation and evaluation of transdermal patches of papaverine hydrochloride, Asian Journal Of Pharmaceutics 4(1),79-86.
Mamatha,T.,Venkateswara J.R.,Ramesh,G.,2010. Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in- vitro characterization,DARU : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences 18(1),9-16.
Dey, S. Malgope,A.,2010.Preparation of carvedioltrnadermal patch and the effect of propylene glycol on permeation ,International Journal of Pharmacy and Pharmaceutical Sciences 2(1),137-143.
Shankar, M.S.,Kulkarni,V.S.,Sandeep H.N.,KumarR.P., Rao,S.,Kumar,A. P.,2010. Development and Evaluation of Acelofenac Transdermal patches using hydrophilic and hydrophobic polymers, Journal of Global Pharma Technology 2(4),102-109
Iman,I.S., Nadia,A.S.,Ebtsam,M. A.,2010. Formulation and stability study of chlorpheniramine maleate transdermal patch, Asian journal of Pharmaceutics4(1),17-23
Sharma,S.,Aggarwal,G., Dhawan,S.,2010. Design and evaluation of Olanzapine transdermal patches containing vegetable oils as permeation enhancers, Scholars Research Library 2(6),84-98
Naohiro, N.,Kazuhiro, T., Toshihiro, S.,Yoichi, M.,2010. Development and evaluation of a monolithic drug-in-adhesive patch for valsartan,International Journal of Pharmaceutics 402,103-109.
Chauhan,I., Bajpai,M.,2010. Formulation and evaluation of transdermal drug delivery of raloxifene hydrochloride, International Journal of Pharmaceutical Sciences and Research1(12),72-79.
Shinde,A.K.J.Shinde,A.L., More,H.N.2010. Design and evaluation of transdermal drug delivery system of gliclazide,Asian Journal of pharmaceutics 4(2),121-129
Bagchi,A.,Kumar,B. D.,2010. Formulation, In-vitro Evaluations and Skin Irritation Study of Losartan Potassium Transdermal Patches,Iranian Journal of Pharmaceutical Sciences 6(3),163-170.
Hasan,Md. K.,Rahman,Md. A.,Shahin,S. M., Islam,Md.
A. U., 2010.In Vitro and In Vivo Evaluation of a RosiglitazoneMaleate-loaded HPMC-PVA Blend Patch,Bangladesh Pharmaceutical Journal13(2),60- 63.
Bharkatiya,M., Nema,R.K., Bhatnaga,M.,2010.Deve lopment and characterization of transdermal pat ches of metoprolol tartrate,Asian Journal of Pharmac eutical and Clinical Research 3(2),130-134
Updesh,B. Lade,Yogesh M. Amgaonkar, Rupesh V. Chikhale, Dinesh M. Biyani, Milind J. Umekar,2011. Design, Formulation and Evaluation of Transdermal Drug Delivery System of Budesonide, Pharmacology & Pharmacy 2, 199-211
Nayak,B. S.,Ellaiah,P.,Pattanayak,D., Das,S.,2011. Formulation design preparation and in vitro characterization of nebivolol transdermal patches,Asian Journal of Pharmaceutics 5(3),175- 182.
Adhyapak,A., Desai,B.G.,2011. Preparation and in vitro characterization of the transdermal drug delivery system containing tamoxifen citrate for breast cancer ,Asian journal of pharmaceutics 5(1),41-45.
K. Kavitha, More M.Rajendra,2011. Design and evaluation of transdermal films of lornoxicam, International Journal of Pharma and Bio Sciences 2(2),54-62.
Darwhekar,G.,Jain,D.K.,Patidar,V. K., 2011. Formulation and Evaluation of Transdermal Drug Delivery System of ClopidogrelBisulfate,Asian Journal of Pharmacy and Life Science 3(1),269-278.
Ansari,K.,Singhai,A., Kumar, S.,Gaurav, K., Patil S.,2011. Transdermal Drug Delivery of Salbutamol Sulphate with DifferentConcentration of Polymers, International Journal of Research in Pharmacy and Science 1(3),50-65.
Hanan El-Nahas, GhazyFakhry, Hanaa El-Ghamry, Sabry, Shereen,2011. Effect of various penetration enhancers concentrations on diclafenac sodium release from cellulose acetate phthalate polymeric film, Asian journal of Pharmaceutics 5(1),33-40.
Parthasarathy,G.,Bhaskar,K. R.,Prasanth,V. V.,2011.formulation and characterization of transdermal patches of naproxen with various polymers, International journal of comprehensive pharmacy 02(06),1-3.
Narasimha,R. R.,Askulla,S.,Bhavya, B. ,Prasoona C.,Pavani K.,2011. Design and Evaluation of Glipizide Transdermal Patches, International Journal of Research in Pharmaceutical and Biomedical Sciences 2(4),1620-1633.
Prajapati,S.T., Patel,C. G., Patel,C. N., 2011. Formulation and Evaluation of Transdermal Patch of Repaglinide, International Scholarly Research Network 11,1-10.
Prabhu,P.,Shah,S.,Gundad,S.,2012.Formulation,Deve lopment and investigation of domperidone transdermal patches,International journal of pharmaceutical investigation 1(4),240-246.
Kumar, R.S.,Jain,A. Nayak,S.,2012. Development and evaluation of transdermal patches of Colchicine, Der Pharmacia Lettre, 4(1),330-343.
SujaChathoth, C Ramasami, Narayanacharyulu Rompicharla,2012. Effect of penetration enhancers on the permeability characteristics of lisinopril transdermal delivery systems,Asian Journal of Pharmaceutics 6(2),130-136.
Sarfaraj,M.D.,Reddy,J.,Hiremath,D.,Udupi,R.H.,2012
.Trimetazidine hydrochloride transdermal patch: Formulation and in-vitro evaluation ,International research journal of pharmacy 3(7),178-182.
Chaudhary, H.,Rana,A.C., Saini,S., Singh,G.,2012. Formulation and evaluation of fexofenadine hydrochloride transdermal patch,Journal of Drug Delivery & Therapeutics 2(5), 20-23.
Banerjee,A.,Rashid,M.H.L.,Chakraverty,R.,Dey,S.,Bas ak,D.,Biswas,C.,2012. Preparation and evaluation of aspirin transdermal patch using hpmc,Int. J. Pharm. Sci. 15(1),45-46
Jadhav,J. K.,Sreenivas,S.A.,2012. Formulation and invitroevaluation of indomethacin transdermal patches using polymers hpmc e5 and ethyl cellulose, International Journal of Pharmacy and Pharmaceutical Sciences 4(1),550-556.
Shrivastava,D.,2012. Transdermal approach of antidiabetic drug glibenclamide: a review,World journal of pharmacy and pharmaceutical sciences 1(2),532-544.
Honglei Xi, Yonggang Yang, Dongmei Zhao, Liang Fang, Lin Sun, Liwei Mu, JieLiu,NanxiZhao,Yanyan Zhao, Ni Zheng, Zhonggui He,2013. Transdermal patches for site-specific delivery of anastrozole: In vitro and local tissue disposition evaluation, International Journal of Pharmaceutics 391, 73–78.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array